← SynDRA
ANPIRTOLINE
SynDRA canonical compound SYN0024962 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HTR1B |
|---|
| Mechanism of action | Serotonin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor agonist
- HTR1B MODULATOR
- HTR1A MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- APEX1
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- HDAC6
- TDP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Anpirtolina
- D-16949
- Anpirtolinum
- DTXCID5025659
- 6-chlor-2-(piperidyl-4-thio)pyridine
- 6-chloro-2-(piperidyl-4-thiol)pyridine
- RefChem:112921
- Anpirtoline [INN]
- Anpirtoline free base
- 4-((6-Chloro-2-pyridyl)thio)piperidine
- 2-chloro-6-piperidin-4-ylsulfanylpyridine
- NCGC00024740-02
- 2-Chloro-6-(piperidin-4-ylthio)pyridine
- Anpirtolinum [Latin]
- Anpirtolina [Spanish]
- CAS-98330-05-3
- UNII-32K9S228IK
- 2-chloro-6-(piperidin-4-ylsulfanyl)pyridine
- Tocris-0703
- Biomol-NT_000088
- SCHEMBL398427
- BPBio1_001089
- orb1741292
- CHEBI:92968
- GGALEXMXDMUMDM-UHFFFAOYSA-N
- Tox21 110922
- Tox21_110922
- PDSP1_001397
- PDSP2_001381
- Tox21_110922_1
- NCGC00024740-01
- NCGC00024740-03
- NCGC00024740-04
- DA-00063
- CS-0088814
- NS00121596
- 2-Chloro-6-[(piperidin-4-yl)sulfanyl]pyridine
- T68189
Look up ANPIRTOLINE in the interactive SynDRA portal →